BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses [Yahoo! Finance]
BiomX Inc. COmmon Stock (PHGE)
Company Research
Source: Yahoo! Finance
Research and Development Expenses: $7.3 million for Q3 2024, up from $5.6 million in Q3 2023. General and Administrative Expenses: $3.2 million for Q3 2024, up from $2.2 million in Q3 2023. Goodwill Impairment Expenses: $801,000 in Q3 2024, related to the APT acquisition. Net Income: $9.6 million for Q3 2024, compared to a net loss of $7.9 million in Q3 2023. Net Cash Used in Operating Activities: $30.7 million for the nine months ended September 30, 2024, compared to $15 million for the same period in 2023. Warning! GuruFocus has detected 2 Warning Signs with PHGE. Release Date: November 14, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript BiomX Inc ( PHGE ) completed patient enrollment for the phase two trial of BX 201 for diabetic foot osteomyelitis, with topline results expected in Q1 2025. The company received additional funding from the US Defense Health Agency, bringing total non-dilutive funding for the
Show less
Read more
Impact Snapshot
Event Time:
PHGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHGE alerts
High impacting BiomX Inc. COmmon Stock news events
Weekly update
A roundup of the hottest topics
PHGE
News
- Microbiome Sequencing Services Business Report 2024-2030: Strong Investment in Genomics Research Crucial for Market Growth [Yahoo! Finance]Yahoo! Finance
- Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI [Yahoo! Finance]Yahoo! Finance
- BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]Yahoo! Finance
- BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program UpdatesGlobeNewswire
- BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024GlobeNewswire
PHGE
Earnings
- 11/14/24 - Beat
PHGE
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 11/13/24 - Form SCHEDULE
- PHGE's page on the SEC website